Medical Devices Australia

Australia ENT Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia ENT Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $365.7 Mn Placeholder estimate
Estimate 2025 $392.8 Mn 1.4% of the global market
Projected 2034 $746.7 Mn 90.1% Adds $354.0 Mn over 9 forecast years
CAGR 2025–2034 7.4% Faster than 10% of 173 Medical Devices markets here
Key players 5
  • Australia is 1.36% of the global market.
  • In APAC, the largest is China at $2.10 Bn.
  • Fastest growing: India at 8.2% a year.
  • Australia ranks 4th of 10 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$354.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
ENT Devices Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $365.7 Mn — —
2025 (base) $392.8 Mn +$27.1 Mn —
2026 (forecast) $421.8 Mn +$29.1 Mn +7.4%
2027 (forecast) $453.0 Mn +$31.2 Mn +15.3%
2028 (forecast) $486.6 Mn +$33.5 Mn +23.9%
2029 (forecast) $522.6 Mn +$36.0 Mn +33.1%
2030 (forecast) $561.2 Mn +$38.7 Mn +42.9%
2031 (forecast) $602.8 Mn +$41.5 Mn +53.5%
2032 (forecast) $647.4 Mn +$44.6 Mn +64.8%
2033 (forecast) $695.3 Mn +$47.9 Mn +77%
2034 (forecast) $746.7 Mn +$51.5 Mn +90.1%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia ENT Devices Market Analysis at a glance
Market size, 2025$392.8 Mn placeholder estimate
Forecast, 2034$746.7 Mn placeholder estimate
Growth (CAGR), 2025–20347.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, setting and end user (see all)
Key playersMedtronic, Karl Storz SE & Co. KG, Olympus Corporation, Stryker, Cochlear (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia ENT Devices Market Analysis Executive Summary

ENT devices diagnose and treat ear, nose and throat problems, from scopes and balloons to hearing implants.

Key segments of the ENT Devices market include product (Diagnostic Scopes, Balloon Sinus Dilation and Powered Surgical Instruments) and setting (Hospitals, ENT Clinics and Ambulatory Surgery Centers).

Bar chart: Australia ENT Devices market size, 2024–2034, placeholder estimates. $365.7 Mn in 2024, $392.8 Mn in 2025 and $746.7 Mn in 2034, 7.4% CAGR.
Australia ENT Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia ENT Devices Market Dynamics

Market Growth Drivers

Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the ENT Devices market.

Opportunity

Home-based diagnosis, smaller connected devices and office-based procedures give the ENT Devices market room to grow.

Market Restraints

Device costs, patients stopping therapy, limited reimbursement and supply issues after recalls hold back the ENT Devices market.

Competitive Landscape for ENT Devices Market in Australia

The ENT Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for ENT Devices Market in Australia

ENT Devices in Australia: rules and payment

Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how ENT Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in ENT Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

ENT Devices in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 15 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 3rd highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the ENT Devices market in Australia?
Placeholder estimate: about $392.8 Mn in 2025, rising to about $746.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the ENT Devices market in Australia growing?
Placeholder estimate: about 7.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the ENT Devices market report cover?
The report splits the market by product (Diagnostic Scopes, Balloon Sinus Dilation, Powered Surgical Instruments, Hearing Implants and more), setting (Hospitals, ENT Clinics, Ambulatory Surgery Centers) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the ENT Devices market?
Key players include Medtronic, Karl Storz SE & Co. KG, Olympus Corporation, Stryker and Cochlear.
What is driving the ENT Devices market?
Rising rates of sleep apnea, sinus disease and hearing loss, an ageing population and less invasive treatments are driving the ENT Devices market.
Who regulates ENT Devices in Australia?
Medical devices must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
How much research is published on ENT Devices?
PubMed lists 357 papers on ENT Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Australia

See all

Related on hearing and surgery

See the topic